Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801
Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S9700
A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients with Locally Advanced Unresected Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-1997
Closed
06-19-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9629
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer
Activated
05-15-1997
Closed
03-15-1999
Closed
Phase
SWOG Clinical Trial Number
SWOG-9444
Gastrointestinal Tumor Repository Protocol, Ancillary
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1997
Closed
09-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9511
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
Activated
01-15-1997
Closed
11-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9413
Phase II Treatment with Etoposide (E), Leucovorin (L), 5-Fluorouracil (F) and Interferon Alpha 2b (I), (ELFI) + G-CSF for Locally Advanced or Recurrent Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-1995
Closed
03-15-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9420
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1995
Closed
05-15-1999
Closed
Phase
SWOG Clinical Trial Number
SWOG-9419
Tumor Tissue Biopsy for Thymidylate Synthase Expression in Patients with Colorectal Cancer, Ancillary
Research Committee(s)
Gastrointestinal Cancer
Activated
03-15-1995
Closed
08-15-2001
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer, Intergroup.
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-1994
Closed
12-15-1999
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9304 (INT-0144)
Postoperative Evaluation of 5-FU by Bolus Injection versus 5-FU by Prolonged Venous Infusion Prior to and Following Combined Prolonged Venous Infusion Plus Pelvic XRT Versus Bolus 5-FU Plus Leucovorin Plus Levamisole Prior to and Following Combined Pelvic XRT in Patients with Rectal Cancer, Phase III, Intergroup
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
08-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9339
Evaluation of Topotecan in Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
12-15-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9241
Evaluation of Topotecan in Colorectal Cancer, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
07-15-1993
Closed
11-15-1994
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9157
Trial of All Trans-Retinoic Acid in Hepatoma, Phase II.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-1993
Closed
08-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9041
Chemoprevention of Recurrent Adenomas and Second Primary Colorectal Carcinoma, A Phase III Pilot Study
Activated
02-01-1993
Closed
04-15-1999
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9100
A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma
Activated
01-15-1993
Closed
08-01-1994
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-9107
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer
Activated
01-01-1993
Closed
08-01-1994
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-9150
Evaluation of Topotecan in Gastric Cancer, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
07-15-1992
Closed
10-15-1993
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9135
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-1992
Closed
01-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9051
Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1992
Closed
04-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9151
Evaluation of Topotecan in Hepatoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-1992
Closed
06-15-1993